Ethnopharmacology, phytochemistry, pharmacology and toxicity of the genus Gouania Authors: Hannington Gumisiriza, Eunice Apio Olet, Lydia Mwikali, Racheal Akatuhebwa, Owen Kembabazi, Timothy Omara, Julius Bunny Lejju Published: 2024 ABSTRACT The genus Gouania (Rhamnaceae) comprises at least 50 recognized species distributed across tropical and subtropical regions. Gouania species have been ethnomedicinally used to treat a variety of ailments. Despite their widespread medicinal use, there is no comprehensive documentation that consolidates the ethnobotanical knowledge, phytochemicals, pharmacological properties, and toxicity of Gouania species. Herein, this review details the ethnopharmacology, phytochemical constituents, pharmacological properties and toxicity of Gouania species to provide perspectives for future research on this genus. Based on available literature, herbal preparations from Gouania species have been used to treat ailments related to the digestive, cardiovascular, respiratory, skin, musculoskeletal, reproductive, endocrine and urological systems. Extracts and isolated compounds from seven Gouania species (G. leptostachya, G. longipetala, G. lupulozdes, G. macrocarpa, G. longispicata, G. obtusifolia, and G. ulmifolia) have demonstrated promising anticancer, antimicrobial, antioxidant, and antiviral properties, supporting their ethnomedicinal uses. To date, 64 compounds (including 6 phenolic compounds, 24 flavonoids, and 34 terpenoids) have been isolated and characterized in the genus mainly as gouaniasides I-IX, gouanogenins, and gouanic acids. Most Gouania species remain unexplored for their potential bioactivities. The identification of more than 54 % as novel compounds from just seven Gouania species highlights the genus as a promising source for discovering new therapeutic agents to combat the growing challenge of multidrug-resistant pathogens. Conducting extensive phytochemical and pharmacological analyses across a broader array of Gouania species could unveil a more comprehensive profile of bioactive compounds, and pave way for innovative treatments against a diverse range of pathogens and diseases. Introduction The Gouania Jacq. genus comprises of up to 70 distinct taxa in the buckthorn family (Rhamnaceae) [1]. The genus was established in 1763 by Jacquin based on two species from Haiti ("Domingensibus") namely: G. tomentosa and G. glabra [2,3]. The genus name commemorates Antoine Goüan (1733–1821), a pioneer in Linnaean taxonomy [4]. Gouania was classified as monophyletic within the tribe Gouanieae by Endlicher [5], a classification which was later reconfirmed by Richardson [6]. These plants are characterized as evergreen woody vines or climbing shrubs [7], with distinctive features that sets them apart from other genera in the family [8,9]. The plants feature alternate leaves, typically serrated with glandular teeth, and small persistent stipules, while the (bisexual) flowers are actinomorphic and arranged in spikes, racemes, or panicles. The flowers are characterized by bell-shaped hypanthium and yellowish-green to whitish hood-shaped petals, with stamens often hooded by petals and arranged around a cup-shaped nectary disk. The ovary is inferior, with 3 locules each containing a single ovule while the fruit is a three-winged schizocarp, splitting into three indehiscent sections with shiny obovate seeds [3]. Gouania species are native to tropical zones of Africa (including Madagascar), Australia, Hawaii, Indian Ocean Islands, and Southern Asia [6,8,10,11], Mediterranean and Western Pacific [12]. A revision by Cahen [7] recognized five Gouania species in Philippines and Sundaland basing on morphological evidences (including a newly described species, G. longipedunculata). Another study reported that two species (G. leptostachya and G. maderaspatana) are endemic to India [13]. A taxonomic revision of the genus Gouania for Madagascar and the other Western Indian Ocean Islands recognized 17 distinct species, of which nine (9) were newly described [4]. Seventeen Gouania species were reported in Brazil, out of which only Gouania ulmifolia Hook. & Arn. grows in Rio Grande do Sul, but is also found in Southern Brazil, Uruguay and Argentina [14]. Since the last two decades, some Gouania species were cited to be critically endangered [8], which calls for establishment of conservation strategies and policies towards sustainability of such species. For instance, a single-island endemic Gouania meyenii discovered on Kauai in 1991 by Lorence & Flynn was last observed in 1994, and concerted efforts to relocate it were unsuccessful until the plants were rediscovered in 2020 by drone survey in Kalalau Valley, where conservation collections have been made [15]. Gouania species hold significant ecological and medicinal importance in their distributional ranges. They contribute to the biodiversity of ecosystems by providing habitat and food for animals, maintaining soil stability and preventing soil erosion. Members of this genus are renowned for their extensive bioactivities and thus use in ethnomedicine [16]. Gouania species feature prominently in traditional medicine where they are used to address cardiovascular, musculoskeletal, respiratory, skin, endocrine, urological, genital and digestive disorders [14,[16], [17], [18], [19], [20], [21]]. Gouania species have appreciable antimicrobial [14,22], anti-inflammatory [23], antidiabetic, antilipidemic, antioxidant [18], and estrogenic effects [20] among other bioactivities. The extensive ethnomedicinal applications of the genus Gouania is not surprising given its status as a promising source of novel constituents, with compounds like gouanogenins, gouaniasides, and gouanic acids, which are named after the genus [13,14,[24], [25], [26]]. Triterpenes are reported to be the most abundant phytochemicals in the Gouania genus, followed by flavonoids [25,[27], [28], [29]]. Studies on these compounds have exhibited diverse bioactivities including antioxidant, neuraminidase inhibition, anticancer, and antibacterial effects [25,27,28]. Despite their widespread medicinal use, there is no comprehensive documentation that consolidates the ethnobotanical knowledge, phytochemistry, pharmacology, and toxicity of the genus. Herein, this review collated literature on the ethnopharmacology, phytochemical constituents, pharmacological properties and toxicity of Gouania species to provide perspectives for future research on this genus. Ethnomedicinal uses of Gouania species Gouania species are used to treat up to 84 ailments, encompassing conditions affecting the digestive, cardiovascular, respiratory, skin, musculoskeletal, reproductive, endocrine and urological systems (Table 1). As an example, G. longipetala aerial parts (stems and leaves) are used in traditional medicine for the treatment of a variety ailments such as swelling, pain, gout, lumbago, venereal diseases, female infertility and cardiovascular diseases [27,30]. In Nigeria, G. longipetala has been used as genital stimulant and laxative [18]. The leaves of G. longispicata are used in Uganda to treat stomachache [17], opportunistic infections among HIV/AIDS patients [31] and over other 40 ailments including; allergy, and urinary retention [32]. In Ethiopia, G. longispicata is used to treat of oral thrush [33], leprosy and leukoderma [34].Table 1Ethnobotanical uses of Gouania species based on published literature.Table 1SpeciesDisease/conditions treatedParts usedPreparation and administrationCountryReferencesGouania longispicata Engl.Foetal troubles, anorexia, oral thrush, stomachache, increasing strength in children, swelling in groin, boils, ulcers, malaria, allergy, febrile seizures, urinary retention, palpitations, heat rash, mastitis, syphilis, limb pains, syphilis, sweating, tooth decay, wounds, itching eyes, inflammations, colic pain, itching vagina, worms, hypertension, dizziness, asthma, body weakness, lactation insufficiency, typhoid, leprosy, leukoderma, hasten child birth, treat stomachache and malaria, lung and skin cancers, babesiosis and constipation in livestockSap, stem exudate, leaves, rootsInfusion taken orally, ointment, teaUganda, Tanzania, Rwanda, Cameroon,Ethiopia, Democratic Republic of Congo[17,[31], [32], [33], [34],[57], [58], [59], [60], [61], [62], [63], [64]]Gouania longipetala Hemsl.Swelling, diabetes mellitus, gout, venomous stings, women infertility, cardiovascular diseases, snake bites, edema, venereal diseases, lumbago, malaria, pain, febrifuges, wounds, abdominal pain, cleaning of the born baby, body sweats, wounds, abdominal pain, genital stimulant, laxative, eye treatments, pain killer, heart diseases, lumbago, rickets, skin disorders, analgesic, sore eyes, conjunctivitis, iritis, ophthalmia, trachoma, gastro-intestinal problems, gynecological complaintsStem, leaves, aerial parts, sapDecoction/infusion taken orally, ointment, eye dropsCameroon, South East Asia, Nigeria, Ghana[16,18,20,30,[65], [66], [67], [68], [69]]Gouania lupuloides Urb.Teeth cleaning, hypertension, malignant ulcers, pneumonia, depurative, diabetes, leishmaniasisRoot, stem, sap, barkDecoction taken orally, brushing teeth, topical applicationJamaica, Cuba, Costa Rica, Mexico, Ecuador[24,36,37,40,43,70]Gouania leptostachya DC.Sores, numbness, stomachache, diarrhea, inflammations, postpartum herbal bath, food supplement, antispasmodic, fainting, leucorrheaLeaves, stem, rootPoultice, cold infusion or decoction taken orally, bathing, smoke inhalation, potionIndia, Indonesia, Thailand, Vietnam, Bhutan, Nepal[13,41,44,45,[71], [72], [73]]Gouania macrocarpa DC.Body painRootCold infusion mixed with rice gruel and taken orallyIndia[13]Gouania javanica Miq.Oral thrushStemBubbles are blown to the thrushPhilippines[46]Gouania mauritiana Lam.Obesity, diabetes, gastroenteritis and inflammationsLeaf, stemNot reportedFrance[21,47]Gouania scandens (Gaertn.) R.B.Drumm. (Synonym: Gouania tiliifolia Lam.)Emmenagogue, diuretic in dropsyNot reportedNot reportedMauritius[48]Gouania latifolia ReissekUterine inflammation and back painBast, leavesNot reportedBrazil[49]Gouania tiliifolia Lam.CoughLeavesCrushMadagascar[50]Gouania polygama (Jacq.) Urb.Hypertension, skin infections, stomachic, depurative and diuretic propertiesLeavesdecoction and fermentation of G. polygama with Smilax domingensis and Pimenta dioica with cane sugarCuba, Mexico[51,52]Gouania tiliaefolia Lam.Liver disease, wounds, sores, ulcers, fever, headacheLeaves, whole plantLeaf juice, poultice on soresIndia, Bangladesh, Philippines[53,[74], [75], [76], [77]]Gouania meyenii Steud.Fever, headache, skin diseasesNot reportedNot reportedHawaii[15] Table 1Ethnobotanical uses of Gouania species based on published literature.Table 1SpeciesDisease/conditions treatedParts usedPreparation and administrationCountryReferencesGouania longispicata Engl.Foetal troubles, anorexia, oral thrush, stomachache, increasing strength in children, swelling in groin, boils, ulcers, malaria, allergy, febrile seizures, urinary retention, palpitations, heat rash, mastitis, syphilis, limb pains, syphilis, sweating, tooth decay, wounds, itching eyes, inflammations, colic pain, itching vagina, worms, hypertension, dizziness, asthma, body weakness, lactation insufficiency, typhoid, leprosy, leukoderma, hasten child birth, treat stomachache and malaria, lung and skin cancers, babesiosis and constipation in livestockSap, stem exudate, leaves, rootsInfusion taken orally, ointment, teaUganda, Tanzania, Rwanda, Cameroon,Ethiopia, Democratic Republic of Congo[17,[31], [32], [33], [34],[57], [58], [59], [60], [61], [62], [63], [64]]Gouania longipetala Hemsl.Swelling, diabetes mellitus, gout, venomous stings, women infertility, cardiovascular diseases, snake bites, edema, venereal diseases, lumbago, malaria, pain, febrifuges, wounds, abdominal pain, cleaning of the born baby, body sweats, wounds, abdominal pain, genital stimulant, laxative, eye treatments, pain killer, heart diseases, lumbago, rickets, skin disorders, analgesic, sore eyes, conjunctivitis, iritis, ophthalmia, trachoma, gastro-intestinal problems, gynecological complaintsStem, leaves, aerial parts, sapDecoction/infusion taken orally, ointment, eye dropsCameroon, South East Asia, Nigeria, Ghana[16,18,20,30,[65], [66], [67], [68], [69]]Gouania lupuloides Urb.Teeth cleaning, hypertension, malignant ulcers, pneumonia, depurative, diabetes, leishmaniasisRoot, stem, sap, barkDecoction taken orally, brushing teeth, topical applicationJamaica, Cuba, Costa Rica, Mexico, Ecuador[24,36,37,40,43,70]Gouania leptostachya DC.Sores, numbness, stomachache, diarrhea, inflammations, postpartum herbal bath, food supplement, antispasmodic, fainting, leucorrheaLeaves, stem, rootPoultice, cold infusion or decoction taken orally, bathing, smoke inhalation, potionIndia, Indonesia, Thailand, Vietnam, Bhutan, Nepal[13,41,44,45,[71], [72], [73]]Gouania macrocarpa DC.Body painRootCold infusion mixed with rice gruel and taken orallyIndia[13]Gouania javanica Miq.Oral thrushStemBubbles are blown to the thrushPhilippines[46]Gouania mauritiana Lam.Obesity, diabetes, gastroenteritis and inflammationsLeaf, stemNot reportedFrance[21,47]Gouania scandens (Gaertn.) R.B.Drumm. (Synonym: Gouania tiliifolia Lam.)Emmenagogue, diuretic in dropsyNot reportedNot reportedMauritius[48]Gouania latifolia ReissekUterine inflammation and back painBast, leavesNot reportedBrazil[49]Gouania tiliifolia Lam.CoughLeavesCrushMadagascar[50]Gouania polygama (Jacq.) Urb.Hypertension, skin infections, stomachic, depurative and diuretic propertiesLeavesdecoction and fermentation of G. polygama with Smilax domingensis and Pimenta dioica with cane sugarCuba, Mexico[51,52]Gouania tiliaefolia Lam.Liver disease, wounds, sores, ulcers, fever, headacheLeaves, whole plantLeaf juice, poultice on soresIndia, Bangladesh, Philippines[53,[74], [75], [76], [77]]Gouania meyenii Steud.Fever, headache, skin diseasesNot reportedNot reportedHawaii[15] Ethnobotanical uses of Gouania species based on published literature. The stems of G. lupuloides (Jamaican chewstick) have been used for teeth cleaning among African-Jamaicans for centuries [24,35]. Traditionally, a pencil-size piece of the bitter vine is chewed on one end to cause extensive foam and is then used to brush the teeth and massage the gums. As a result, G. lupuloides extracts have been in market as a mouthwash and dentifrice throughout Jamaica [24]. The Negroes grind stems of G. lupuloides in water and use it as antiseptic mouthwash or toothbrush [36]. The roots and stems of G. lupuloides are used to treat hypertension, while the sap is used to treat athlete's foot [37]. Gouania lupuloides is also used in traditional medicine in Cuba [38], Costa Rica [39] and Ecuador [40]. The leaves of G. leptostachya are used by the Lepcha (a tribe of Himalayan range living at the North-East corner of India) to make poultices for treating sores [13]. Leaves and stems of G. leptostachya are used by the Indonesians for treatment of stomachache and diarrhea [41]. The Mien of Northern Thailand use G. leptostachya as a postpartum herbal bath formula and food supplement, and also to treat convulsion in new born, numbness, fainting [42] and inflammations [23]. The rural folks of North Andaman, India burn the roots of G. leptostachya and then inhale the smoke to treat fever [43]. Paste made from the leaves of G. leptostachya is used to cure sores and inflammation in India [44,45]. The stem of G. javanica is used to treat fungal infections [46]. Gouania mauritiana is traditionally used to reduce cases of obesity and diabetes [21], gastroenteritis and inflammations [47]. G. scandens is used as an emmenagogue and diuretic in dropsy [48]. G. latifolia is used to treat uterine inflammation and back pain [49]. Leaf decoction of G. tiliifolia is orally taken in Madagascar for respiratory disorders [50]. G. polygama is used to make a traditional Cuban medicinal refreshment beverage produced by fermentation of a decoction of multispecies plants, chiefly with Smilax domingensis, Pimenta dioica and cane sugar [51]. G. polygama leaf is used to treat skin infections [52]. In India, Gouania tiliaefolia is used in Indian ethnomedicine for liver complaints [53], while the infusion from roots of G. macrocarpa is consumed to treat body pain [54]. Overall, leaves and stems are the most used parts of species of the Gouania genus for treatment of diseases (Fig. 1). The use of leaves may be related to their accessibility and abundance throughout the year, and their principal photosynthetic role and in the storage of therapeutic phytochemicals [55,56].Fig. 1Frequency of use of different parts of Gouania species for preparation of herbal remedies.Fig. 1 Frequency of use of different parts of Gouania species for preparation of herbal remedies. Phytochemistry of species in the Gouania genus Several phytochemical screening reports have been made on members of the Gouania genus. For instance, G. longipetala stem ethanolic extract was reported to contain reducing sugars, triterpenoids, phenolics, phytosterols, saponins and flavonoids, with total phenolic content of 52.02 mg/g tannic acid equivalent [16]. Crude extracts of G. longipetala leaves contained alkaloids, phenols, saponins, flavonoids, steroids, tannins, terpenoids and cardiac glycosides with concentrations of 34.30, 23.19, 18.10, 16.49, 13.74, 9.72, 7.45 and 3.89 mg/100 g, respectively. Furthermore, GC-MS analysis of G. longipetala leaf extract revealed that it had 20 compounds. These included spartein (constituting up to 24.92 %), 2-tetradecanol, dodecanoic acid, 1-octadecene, luparine, 5,6-dehydrolupanine, propanoic acid-3-chloro-methyl ester, sapogenine, catechin, flavon-3-ol, anthocyanin, resveratrol, linoelaidic acid, aragyrine, methyl-9,12-heptadecadienoate, baptifoline, oleic acid, spartein, kaempferol and ethyl oleate [78]. Different solvent extracts of G. longispicata were qualitatively screened for phytochemicals and reportedly had cardiac glycosides, phenolics, steroids, flavonoids, saponins, and resins [22]. Another study reported that phenols, tannins, alkaloids and resins were present in G. longispicata methanolic leaf extract [79], while the whole plant extract contained polyphenols, flavonoids, triterpenes, sterols and saponins [80]. Similarly, G. longispicata leaf extracts had flavonoids, cardiac glycosides, saponins, steroids, resins and phenolics [22]. In a quantitative study, petroleum ether and methanolic extract of G. tiliaefolia had total phenolic content of 78.30 mg GAE/g and 70.37 mg GAE/g [77]. Phytochemical analysis of G. longipetala leaf extracts quantified vitamin C (2.807 mg/100 g), phenolics (0.375 mg GAE/g) and flavonoids (11.615 μg/g), while the corresponding quantities in the stem extract were 2.126 mg/100 g, 0.299 mg GAE/g and 10.012 μg/g [81]. Some phytochemical studies have been done to isolate and characterize bioactive compounds from Gouania species. These are discussed in the following subsections. Terpenoids from the genus Gouania Terpenoids have been reported to dominate in this genus, with up to 34 of them reported (1-34) (Table 2; Fig. 2). For example, G. lupuloides stem yielded two novel terpenoids (gouanosides A and B) which are 16,17-seco-dammaranoid saponins [24]. A new triterpenic acid (gouanic acid) was also identified in G. macrocarpa leaf extract [13]. In another report, gouanic acid A and B were characterized in G. ulmifolia aerial part extracts [14]. Six new triterpenoid saponins (named gouaniaside I-VI) were characterized from G. longipetala aerial parts [25]. Later, four novel such saponins (named gouaniasides VII–IX), along with joazeiroside C were identified in G. leptostachya aerial parts [26]. A unique and novel ceanothane-type saponin was similarly characterized in G. leptostachya [82]. More recently, an alkyl glycoside (n-butyl-β-D-fructopyranoside) was characterized from G. leptostachya [82].Table 2Terpenoids reported from the genus Gouania.Table 2TerpenoidSpeciesPart usedReferencesGouanic acid (1)G. microcarpaLeaves[13]Tetratriacontanoic acid (2)Gouanic acid A (3)G. ulmifoliaAerial parts[14]Gouanic acid B (4)[14,27]3-O-β-D-glucopyranosyl Gouanogenin A (5)G. longipetala[27]Joazeiroside A (6)G. longipetala, G. leptostachya[1,27]Alphitolic acid (7)[25,27,82]Lupeol (8)[27,82]Betulinic acid (9)G. longipetala[27]β-sitosterol-3-O- β-D-glucoside (10)Gouanogenin A (11)G. lupulozdesStem[24]Gouanogenin B (12)Ebelin lactone (13)Gouanoside A (14)Gouanoside B (15)Progouanogenin (16)3-O-β-D-glucopyranosyl gouanogenin A (17)Gouaniaside I (18)G. longipetalaAerial parts[25]Jujuboside I (19)Gouaniaside II (20)Gouaniaside III (21)Gouaniaside IV (22)Gouaniaside V (23)Terminolic acid (24)Gouaniaside VI (25)n-butyl-β-D-fructopyranoside (26)G. leptostachya[82]Gouaniaside VII (27)G. leptostachya[26]Gouaniaside VIII (28)Gouaniaside IX (29)Joazeiroside C (30)Epigouanic acid A (31)Gouanioside A (32)G. leptostachya[82]Ceanothenic acid (33)Daucosterol (34)Fig. 2Terpenoids characterized in Gouania species (1–34 correspond to the compounds in Table 2).Fig. 2 Table 2Terpenoids reported from the genus Gouania.Table 2TerpenoidSpeciesPart usedReferencesGouanic acid (1)G. microcarpaLeaves[13]Tetratriacontanoic acid (2)Gouanic acid A (3)G. ulmifoliaAerial parts[14]Gouanic acid B (4)[14,27]3-O-β-D-glucopyranosyl Gouanogenin A (5)G. longipetala[27]Joazeiroside A (6)G. longipetala, G. leptostachya[1,27]Alphitolic acid (7)[25,27,82]Lupeol (8)[27,82]Betulinic acid (9)G. longipetala[27]β-sitosterol-3-O- β-D-glucoside (10)Gouanogenin A (11)G. lupulozdesStem[24]Gouanogenin B (12)Ebelin lactone (13)Gouanoside A (14)Gouanoside B (15)Progouanogenin (16)3-O-β-D-glucopyranosyl gouanogenin A (17)Gouaniaside I (18)G. longipetalaAerial parts[25]Jujuboside I (19)Gouaniaside II (20)Gouaniaside III (21)Gouaniaside IV (22)Gouaniaside V (23)Terminolic acid (24)Gouaniaside VI (25)n-butyl-β-D-fructopyranoside (26)G. leptostachya[82]Gouaniaside VII (27)G. leptostachya[26]Gouaniaside VIII (28)Gouaniaside IX (29)Joazeiroside C (30)Epigouanic acid A (31)Gouanioside A (32)G. leptostachya[82]Ceanothenic acid (33)Daucosterol (34) Terpenoids reported from the genus Gouania. Terpenoids characterized in Gouania species (1–34 correspond to the compounds in Table 2). Phenolic compounds from genus Gouania A total of five phenolic compounds (35–40) have been reported in Gouania genus (Table 3; Fig. 3). Mangiferin (39), a well-known glucosylxanthone (xanthonoid) is the most important phenolic compound in this genus that was isolated from G. obtusifolia leaves [28]. This natural phenolic xanthonoid is known to possess excellent bioactivities such as antibacterial and anticancer activities [83]. A phenolic glycoside (named 4,6-dihydroxy-3-methylacetophenone-2-O-β-D-glucopyranoside (40)) was recently characterized from G. longispicata leaves [84].Table 3Phenolic compounds isolated from different parts of species in Gouania genus.Table 3Phenolic compoundSpeciesPartReference1-[(rel 2S,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]ethenone (35)G. leptostachyaStem[85]1-[(rel 2S,3S)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]ethenone (36)Palmarumycin BG1/JC2 (37)G. longipetalaAerial parts[86]de-O-methyllasiodiplodin (38)Mangiferin (39)G. obtusifoliaLeaves[28]4,6-dihydroxy-3-methylacetophenone-2-O-β-D-glucopyranoside (40)G. longispicataLeaves[84]Fig. 3Phenolic compounds characterized in Gouania species (35–40 correspond to the compounds in Table 3).Fig. 3 Table 3Phenolic compounds isolated from different parts of species in Gouania genus.Table 3Phenolic compoundSpeciesPartReference1-[(rel 2S,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]ethenone (35)G. leptostachyaStem[85]1-[(rel 2S,3S)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]ethenone (36)Palmarumycin BG1/JC2 (37)G. longipetalaAerial parts[86]de-O-methyllasiodiplodin (38)Mangiferin (39)G. obtusifoliaLeaves[28]4,6-dihydroxy-3-methylacetophenone-2-O-β-D-glucopyranoside (40)G. longispicataLeaves[84] Phenolic compounds isolated from different parts of species in Gouania genus. Phenolic compounds characterized in Gouania species (35–40 correspond to the compounds in Table 3). Flavonoids from Gouania species To date, it is known that Gouania species contain phenolic compounds, either as phenolics or flavonoids [28,29], signifying their prevalence in this genus. A total of 24 flavonoids (41–64) have been reported in this genus (Table 4; Fig. 4). These include rutin (quercetin-3-O-rutinoside), kaempferol, quercetin and their derivatives. Such flavonoids play essential roles in plant defense mechanisms, contributing to protection against ultraviolet visible radiation, pathogens, and herbivores [87].Table 4Flavonoids isolated from the Gouania genus.Table 4FlavonoidsSpeciesPartReferenceQuercetin 3-O-α-L-rhamnoside (41)G. obtusifoliaLeaves[28]Kaempferol 3-O-α-L-rhamnoside (42)Epicatechin (43)Gallocatechin (44)Engeletin (45)Kaempferol-3-O-(6-O-E-coumaroyl)-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (46)G. longipetalaAerial parts[29]Kaempferol-3-O-(6-O-E-feruloyl)-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (47)Kaempferol- 3-O-α-L-rhamnopyranosyl-(1→6)-β-D-galactopyranoside (48)Kaempferol-3-O-α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside (49)Kaempferol-3-O-α-L-rhamnopyranoside (50)Kaempferol-3-O-β-D-xylopyranosyl-(1→2)-α-L-rhamnopyranoside (51)Kaempferol-3-O-β-D-galactopyr- anosyl-(1→2)-α-L-rhamnopyranoside (52)Quercetin-3-O-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (53)Quercetin-3-O-α- L-rhamnopyranosyl-(1→6)-β-D-galactopyranoside (54)Quercetin-3-O-β-D-xylopyranosyl-(1→2)- -α- L- rhamnopyranoside (55)G. leptostachyaLeaves[1]Quercetin-3-O-6-E-p-coumaroyl-β-D-glucopyranosyl-(1→2)-α-L-rhamnopyranoside (56)Quercitrin (57)G. leptostachyaAerial parts[82]Isoquercitrin (58)Kaempferol-3-O-(6-O-E-caffeoyl)-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (59)Catechin (60)Kaempferol-3-O-α-rhamnopyranoside (61)G. longispicataLeaves[84]Rutin (62)Kaempferol (63)Quercetin (64)Fig. 4Structure of flavonoids isolated and characterized in the Gouania taxon. The numbers 41–64 refer to the molecules mentioned in Table 4.Fig. 4 Table 4Flavonoids isolated from the Gouania genus.Table 4FlavonoidsSpeciesPartReferenceQuercetin 3-O-α-L-rhamnoside (41)G. obtusifoliaLeaves[28]Kaempferol 3-O-α-L-rhamnoside (42)Epicatechin (43)Gallocatechin (44)Engeletin (45)Kaempferol-3-O-(6-O-E-coumaroyl)-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (46)G. longipetalaAerial parts[29]Kaempferol-3-O-(6-O-E-feruloyl)-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (47)Kaempferol- 3-O-α-L-rhamnopyranosyl-(1→6)-β-D-galactopyranoside (48)Kaempferol-3-O-α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside (49)Kaempferol-3-O-α-L-rhamnopyranoside (50)Kaempferol-3-O-β-D-xylopyranosyl-(1→2)-α-L-rhamnopyranoside (51)Kaempferol-3-O-β-D-galactopyr- anosyl-(1→2)-α-L-rhamnopyranoside (52)Quercetin-3-O-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (53)Quercetin-3-O-α- L-rhamnopyranosyl-(1→6)-β-D-galactopyranoside (54)Quercetin-3-O-β-D-xylopyranosyl-(1→2)- -α- L- rhamnopyranoside (55)G. leptostachyaLeaves[1]Quercetin-3-O-6-E-p-coumaroyl-β-D-glucopyranosyl-(1→2)-α-L-rhamnopyranoside (56)Quercitrin (57)G. leptostachyaAerial parts[82]Isoquercitrin (58)Kaempferol-3-O-(6-O-E-caffeoyl)-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (59)Catechin (60)Kaempferol-3-O-α-rhamnopyranoside (61)G. longispicataLeaves[84]Rutin (62)Kaempferol (63)Quercetin (64) Flavonoids isolated from the Gouania genus. Structure of flavonoids isolated and characterized in the Gouania taxon. The numbers 41–64 refer to the molecules mentioned in Table 4. Verily, alkaloids have been phytochemically identified among the secondary metabolites in G. javanica [46], G. longipetala [88], and G. longispicata [79]. However, no alkaloid has been isolated as a pure compound in any species of the Gouania genus. Therefore, future research could probe into the exploration and isolation of alkaloids within this genus. Despite the extensive traditional use of Gouania species reported in literature, characterization of bioactive compounds has been perfected in extracts from only 7 species (G. longipetala, G. leptostachya, G. obtusifolia, G. macrocarpa, G. ulmifolia, G. longispicata and G. lupulozdes). Specifically, G. longipetala has received the most attention in herbal medicine due to its widespread distribution compared to other Gouania species which grow in specific regions. Remarkably, more than 54 % of the yet characterized compounds from the Gouania genus are novel, suggesting its potential as a rich reservoir for discovering new drug leads to combat the growing array of pathogens. Therefore, extensive phytochemical investigations across a broader range of Gouania species beyond the seven investigated taxa could yield more compounds, which could act as scaffolds for development of potential drug candidates. Bioactivity of extracts from Gouania species Antioxidant activity Ethanolic extract of G. longipetala stem had IC50 of 0.004 mg/mL [16]. The DPPH assay of methanolic leaf extract of G. longipetala showed that it exhibited antioxidant activity (16.6 %–65.5 %) [88]. In another study, G. longipetala extract produced a dose-dependent and significant increase in superoxide dismutase and decrease in malondiadehyde [18]. G. longipetala fresh leaf extract lowered malondialdehyde concentration significantly [78]. Petroleum ether extract of G. tiliaefolia had free radical scavenging activity with IC50 of 2.88 μg/mL, while the methanolic extract had IC50 of 4.79 μg/mL [77]. Antimicrobial properties Leaf extracts of G. javanica showed antifungal activity against Aspergillus niger, Candida albicans and Tricophyton mentagrophytes with mean zone of inhibition of 21.16 mm, 12.08 mm and 8.55 mm, respectively [46]. Ethanolic extract of G. longipetala stems exhibited antibacterial effect against Bacillus subtilis, B. thurigiensis, Staphylococcus aureus, Enterococcus faecalis, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella typhi and Escherichia coli, with the lowest MIC of 125 μg/mL against B. subtilis [16]. Recently, G. longispicata leaf extract inhibited growth of S. aureus, Streptococcus pneumoniae, E. coli, P. aeruginosa, Candida albicans and Aspergillus flavus, with Streptococcus pneumoniae being the most susceptible microorganism with MIC of 1.95 mg/mL and minimum bactericidal concentration of 15.625 mg/mL [22]. A similar study determined the antibacterial activity of nine Cameroonian medicinal plants against drug-resistant E. coli, Enterobacter aerogenes, Klebsiella pneumoniae, Providencia stuartii, P. aeruginosa and S. aureus, and the findings revealed that G. longispicata extract gave the broadest spectrum of action notably against 86.4 % of the bacterial strains tested [80]. Tannins, phenols, alkaloids and resins of G. longispicata were considered to be responsible for the potential activity against S. aureus and Streptococcus pneumonia and P. aeruginosa [79]. In another study, G. lupuloides was effective against P. falciparum K1 strain [39] and its stem extracts gave less than 50 % inhibition of Mycobacterium tuberculosis at 50 μg/mL [89]. Antidiabetic activity Leaf extracts of G. longipetala significantly decreased the fasting blood sugar (FBS) levels of diabetic rats from 16.2 mM/L to 6.5 mM/L at 150 mg/kg within 24 h, and the FBS levels decreased by 62.0 %, 74.8 %, and 75.0 % on day 21 at 50 mg/kg, 100 mg/kg, and 150 mg/kg, respectively [88]. Using the oral glucose tolerance test, methanolic extract of G. tiliaefolia reduced blood glucose levels by 71.42 % and 75.39 % at doses 200 and 400 mg/kg-body weight, respectively compared with glibenclamide standard that reduced blood glucose levels by 66.17 % [77]. Anti-inflammatory activity Ethanolic extract of G. longipetala stem bark had a maximal inhibitory effect of total edema by 93.78 % at 300 mg/kg [16]. A study assessing the anti-inflammatory effects of G. leptostachya extracts and fractions by inhibiting nitric oxide production in RAW 264.7 macrophages reported that the effects were concentration-dependent [26]. Another research group concluded that the ethanolic extract and fractions of G. leptostachya induced inflammatory effects by modulating nitric oxide synthesis in lipopolysaccharide-stimulated murine RAW264.7 macrophage cells, suggesting the potential therapeutic utility of G. leptostachya in inflammatory conditions [82]. Other bioactivities There are other bioactivities of Gouania species. For example, the stem bark extract of G. longipetala has been shown to possess estrogenic properties [81]. Extracts of G. tiliaefolia showed insignificant thrombolytic and membrane stabilizing activities results compared to the respective standards [77]. Following castor oil-induced diarrhea, G. tiliaefolia methanol extract gave better reduction of diarrhea by 71.43 % (at 400 mg/kg-body weight) compared to loperamide (64.29 %) [66]. The central- and peripheral-analgesic activity of G. tiliaefolia methanol extract was dose-dependent compared to the standard, diclofenac sodium [77]. A study determined the anti-osteoclastogenesis of G. javanica leaf extracts and the results unveiled its potential as an effective inhibitor of osteoclastogenesis [90]. These components of G. longipetala exhibited various bioactivities including; inhibition of uric acid, amino acid decarboxylase activity, urine acidifiers, oligosaccharide provider, arachidonic acid inhibitor, decrease endothelial leukocyte and platelet adhesion [91]. Bioactivity of isolated compounds Although 64 compounds have been characterized from Gouania genus, only 26 of these have been assessed for their bioactivities, such as antioxidant, anticancer, neuraminidase inhibition, and antibacterial properties (Table 5). Despite the documented isolation of compounds from this genus, scientific evaluation of efficacy, toxicity, and characterization of bioactive compounds has primarily focused on G. longipetala. Nevertheless, plants with significant ethnomedical usage have yielded potent compounds, with some integrated into essential medicines [92], which suggests that the genus Gouania can be a great source of new drug substances.Table 5Bioactivities of compounds isolated from genus Gouania.Table 5CompoundBioactivity testedSpeciesPart usedTreatment/methodIC50 (μM)ReferencesGouanic acid B (4)AntioxidantG. longipetalaAerial partsDPPH method52.5[27]3-O-β-D-glucopyranosyl gouanogenin A (5)56.4Joazeiroside A (6)69.5Alphitolic acid (7)68.2Lupeol (8)63.2Quercetin 3-O-α-L-rhamnoside (40)Neuraminidase inhibitionG. obtusifoliaLeaves200 μg/mL (Neu5Ac2en control IC50 = 44.47)7.89[28]Kaemferol 3-O-α-L-rhamnoside (41)5.47Epicatechin (42)5.49Gallocatechin (43)10.22Engeletin (44)5.44Mangiferin (39)0.824,6-dihydroxy-3-methylacetophenone-2-O-β-D-glucopyranoside (40)AntioxidantG. longispicataLeavesDPPH method26.3[84]AntibacterialBroth dilution methodMIC = 32 μg/mL and 64 μg/mLKaempferol-3-O-(6-O-E-feruloyl)-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (46)AntioxidantG. longipetalaAerial parts100 mg/mL; Ascorbic acid control (IC50 = 60)47.4[29]Kaempferol- 3-O-α-L-rhamnopyranosyl-(1→6)-β-D-galactopyranoside (47)Antioxidant40.4Quercetin-3-O-α- L-rhamnopyranosyl-(1→6)-β-D-galactopyranoside (53)41.5Quercetin-3-O-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (52)AntioxidantG. longipetala13.8Jujuboside I (19)AnticancerHL60 cells13.5Alphitolic acid (7)Antibacterial activityS. aureus,E. faecalis and E. coli (Gentamicin control MIC = 0.5)MIC = 32, 64 and 128 mg/mL, respectivelyGouaniaside VII (27)Anti-inflammatoryG. leptostachyaNO inhibition by RAW 264.7 macrophagesThe level of NO produced decreased in a concentration-dependent manner[26]Gouaniaside VIII (28)Gouaniaside IX (29)Joazeiroside C (30)Gouanioside A (32)Anti-inflammatoryG. leptostachyaNO inhibition by RAW 264.7 macrophagesThe level of NO produced decreased in a concentration-dependent manner[82]Kaempferol-3-O-α-rhamnopyranoside (61)AntioxidantG. longispicataLeavesDPPH method20.0[84]AntibacterialBroth dilution methodMIC = 16 μg/mL and 32 μg/mLRutin (62)AntioxidantDPPH method28.1AntibacterialBroth dilution methodMIC = 16 μg/mL and 32 μg/mLKaempferol (63)AntioxidantDPPH method19.8AntibacterialBroth dilution methodMIC = 32 μg/mL and 125 μg/mLQuercetin (64)AntioxidantDPPH method18.6AntibacterialBroth dilution methodMIC = 64 μg/mL and 32 μg/mLNote: IC50 values are in μM. MIC, Minimum inhibitory concentration. Table 5Bioactivities of compounds isolated from genus Gouania.Table 5CompoundBioactivity testedSpeciesPart usedTreatment/methodIC50 (μM)ReferencesGouanic acid B (4)AntioxidantG. longipetalaAerial partsDPPH method52.5[27]3-O-β-D-glucopyranosyl gouanogenin A (5)56.4Joazeiroside A (6)69.5Alphitolic acid (7)68.2Lupeol (8)63.2Quercetin 3-O-α-L-rhamnoside (40)Neuraminidase inhibitionG. obtusifoliaLeaves200 μg/mL (Neu5Ac2en control IC50 = 44.47)7.89[28]Kaemferol 3-O-α-L-rhamnoside (41)5.47Epicatechin (42)5.49Gallocatechin (43)10.22Engeletin (44)5.44Mangiferin (39)0.824,6-dihydroxy-3-methylacetophenone-2-O-β-D-glucopyranoside (40)AntioxidantG. longispicataLeavesDPPH method26.3[84]AntibacterialBroth dilution methodMIC = 32 μg/mL and 64 μg/mLKaempferol-3-O-(6-O-E-feruloyl)-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (46)AntioxidantG. longipetalaAerial parts100 mg/mL; Ascorbic acid control (IC50 = 60)47.4[29]Kaempferol- 3-O-α-L-rhamnopyranosyl-(1→6)-β-D-galactopyranoside (47)Antioxidant40.4Quercetin-3-O-α- L-rhamnopyranosyl-(1→6)-β-D-galactopyranoside (53)41.5Quercetin-3-O-β-D-galactopyranosyl-(1→2)-α-L-rhamnopyranoside (52)AntioxidantG. longipetala13.8Jujuboside I (19)AnticancerHL60 cells13.5Alphitolic acid (7)Antibacterial activityS. aureus,E. faecalis and E. coli (Gentamicin control MIC = 0.5)MIC = 32, 64 and 128 mg/mL, respectivelyGouaniaside VII (27)Anti-inflammatoryG. leptostachyaNO inhibition by RAW 264.7 macrophagesThe level of NO produced decreased in a concentration-dependent manner[26]Gouaniaside VIII (28)Gouaniaside IX (29)Joazeiroside C (30)Gouanioside A (32)Anti-inflammatoryG. leptostachyaNO inhibition by RAW 264.7 macrophagesThe level of NO produced decreased in a concentration-dependent manner[82]Kaempferol-3-O-α-rhamnopyranoside (61)AntioxidantG. longispicataLeavesDPPH method20.0[84]AntibacterialBroth dilution methodMIC = 16 μg/mL and 32 μg/mLRutin (62)AntioxidantDPPH method28.1AntibacterialBroth dilution methodMIC = 16 μg/mL and 32 μg/mLKaempferol (63)AntioxidantDPPH method19.8AntibacterialBroth dilution methodMIC = 32 μg/mL and 125 μg/mLQuercetin (64)AntioxidantDPPH method18.6AntibacterialBroth dilution methodMIC = 64 μg/mL and 32 μg/mLNote: IC50 values are in μM. MIC, Minimum inhibitory concentration. Bioactivities of compounds isolated from genus Gouania. Note: IC50 values are in μM. MIC, Minimum inhibitory concentration. Among the ten (10) compounds from G. longipetala tested for effects on promyelocytic leukemia HL60 and human erythromyeloblastoid leukemia K562 cell lines, only jujuboside I demonstrated moderate cytotoxicity [25]. Additionally, the antibacterial activity of the isolated compounds against Staphylococcus aureus, Escherichia coli, and Enterococcus faecalis revealed alphitolic acid as the sole compound with significant inhibitory activity against all the three bacteria, giving MIC values ranging from 32 to 128 mg/mL [25]. The first study of bioactive compounds from G. longispicata [84], found that compounds from its leaves methanolic extract (40, 61–64) exhibited antibacterial activity against S. pneumoniae and E. coli with MIC from 16 to 125 μg/mL. The radical scavenging activities of compounds (40, 61–64) from G. longispicata leaves had IC50 between 18.6 μg/mL and 28.1 μg/mL. The IC50 of 63 and 64 were not significantly different from that of ascorbic acid, which indicated their promising utilization as natural antioxidants. Toxicity profile of Gouania species Few toxicity studies have been reported for the genus Gouania. Acute toxicity tests of G. longipetala extract suggested no observable signs of toxicity or morbidity, with LD50 greater than 4000 mg/kg [88], while a sub-chronic study showed that the relative liver weight increased significantly on day 90 at 10 mg/kg [18]. Additionally, changes in hematological parameters were not significant for G. longipetala extract-treated and untreated rats, suggesting that the extract was safe [18]. However, long term therapy of G. longipetala (up to 90 days) suggested toxicity to the liver and kidney, particularly at high doses. Another report found that G. longipetala extract significantly reduced total cholesterol, triglycerides and very low-density lipoproteins, while high density lipoproteins and serum urea increased prominently on day 90 at 10 mg/kg. At all doses of G. longipetala extract tested, liver enzyme markers increased significantly [18]. Acute toxicity study of G. longipetala leaf extract revealed a LD50 > 5000 mg/kg bw, signifying safe oral use of the plant. Also, sub-acute administration did not significantly alter the hematological, hepatic and renal function indices [69]. The petroleum ether extract of G. tiliaefolia gave brine shrimp lethality LC50 = 2.59 μg/mL, while methanolic extract had LC50 of 3.38 μg/mL [77]. These findings imply that Gouania species are safe for traditional use, however, further studies need to be done to give scientific evidence of their safety. Conclusions and future research directions Gouania species are utilized traditionally for treatment of digestive, cardiovascular, respiratory, skin, musculoskeletal, reproductive, endocrine and urological systems ailments. Only seven Gouania species (G. leptostachya, G. longipetala, G. macrocarpa, G. lupulozdes, G. ulmifolia, G. longispicata and G. obtusifolia) have been investigated to date and found to exhibit anticancer, antimicrobial, antioxidant, and antiviral activities. In total, 64 compounds have been so far characterized from Gouania genus but studies targeting their toxicity are still limited. Future research on Gouania species should investigate the phytochemicals and bioactivities of the unstudied species such as G. scandens, G. mauritiana, G. latifolia, G. polygama, G. tiliaefolia and G. meyenii that have been indicated for use in herbal formularies. Given the sparse data on the toxicity profiles of Gouania species, there is a critical need for systematic toxicity studies to ensure their safety when used in herbal medicine. Additionally, conducting clinical studies to assess the efficacy and safety of Gouania extracts and the characterized bioactive molecules could provide valuable insights into their medicinal properties and support the discovery of novel bioactive molecules. CRediT authorship contribution statement Hannington Gumisiriza: Writing – review & editing, Writing – original draft, Funding acquisition, Conceptualization. Eunice Apio Olet: Writing – review & editing, Supervision. Lydia Mwikali: Writing – review & editing. Racheal Akatuhebwa: Writing – review & editing, Data curation. Owen Kembabazi: Writing – review & editing. Timothy Omara: Writing – review & editing, Formal analysis. Julius Bunny Lejju: Writing – review & editing, Conceptualization. Data availability This review generated no raw data. Funding This review was funded by the Faculty of Science, 10.13039/501100009915Mbarara University of Science and Technology (Grant number: 7088522). Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Hannington Gumisiriza reports financial support was provided by 10.13039/501100009915Mbarara University of Science and Technology, Faculty of Science. Hannington Gumisiriza reports a relationship with 10.13039/501100009915Mbarara University of Science and Technology, Faculty of Science that includes: funding grants. All authors have no conflict. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.